MedPath

This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device.

Not yet recruiting
Conditions
Diabetes Mellitus
Registration Number
NCT06965803
Lead Sponsor
Cedars-Sinai Medical Center
Brief Summary

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
37
Inclusion Criteria
  • aged 18 or older
  • diagnosed with Type 1 or Type 2 Diabetes who are on insulin
  • able to speak and understand English language
  • scheduled to receive a standard inpatient diabetes education consultation
  • must not have used CGM in the six months prior to admission
  • owns a smartphone
  • demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program
Exclusion Criteria
  • those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.
  • non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient Satisfaction15 days

Glucose Monitoring Satisfaction Survey

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath